Events

DGE’s 2nd Medical Writing Innovation Strategies Conference for Life Sciences

Date: June 29-30, 2021
Online Livestream Event

Biopharma medical writing and communications professionals are invited are invited to attend DGE’s 2nd Medical Writing Innovation Strategies Conference for Life Sciences live streaming on June 29-30, 2021. The event will offer useful tips and guide medical professionals to learn innovative skills for filtering technical information that is effectively communicated for engagement.

These power-packed sessions will assist medical writers and communicators in elevating their skills that will, in turn, boost their career growth. With the increasing pressure on medical writing, professionals will learn how to diffuse work stress and communicate harmoniously in the work environment. Further, they will also understand the skills of leading through consensus, negotiating, and influencing interpersonal relations.

The event is hosted by Dynamic Global Events (“DGE”), a Life Science leader in organizing B2B events. The global event company caters to the dynamic informational and networking needs of the Pharmaceutical, Biotechnology, Healthcare, Medical Devices, and allied industries.

The event will feature eminent speakers and dignitaries who excel in leadership and communication skills in the medical industry. The conference will start with the Chairperson’s opening remarks, Stephen W. Gutkin, an acclaimed published author and Senior Director, Scientific Publication Writing, Ascentage Pharma Group (OTC: ASPHF) who will provide his valuable insights about the key qualifications for successful medical communicators. 

Thereafter, several speakers will share keynotes and hold discussions on several topics such as:

  • Creating engaging and effective content that is easy to understand for caregivers, health professionals, and patients alike
  • Juggling Multiple Writing Projects with Ease with Project Management Techniques
  • Choosing a field of specialty while still maintaining flexibility
  • Providing accurate and reliable information to patients and study participants
  • Maximizing cross-functional collaborations
  • Understanding medical communications in the digital age while maintaining the accessibility of all resources
  • Achieving exemplary communication skills in medical writing

Attendees will discuss the impact of the pandemic, the new communication guidelines in the digital scenario, and the best ways to engage with the shareholders. The primary takeaway of the event is to ensure the growth of medical professionals and successful communication across all segments of the medical spectrum.

For tickets to the event, please visit https://ibn.fm/tR7Rw

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Committed to Advancing Cancer Care with Innovative RTNova Platform Research

Cancer statistics underscore the urgency of ongoing cancer research and the need for more effective…

1 hour ago

AI Can Predict the Recurrence of Brain Tumors in Kids, Study Finds

A team of researchers has leveraged a technique called temporal learning to train an AI…

2 hours ago

Nutriband Inc. (NASDAQ: NTRB) Leadership Team: Driving Innovation and Shaping the Future of Global Healthcare

Sheridan was recently named as a finalist for the 2025 EY Entrepreneur of the Year…

2 hours ago

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Reports Innovative RTNova Platform Research, Exemplifies Pivotal Role of Research

“Research on the treatment of cancer is fundamental to improving outcomes for all patients affected…

1 day ago

Adageis Offering Comprehensive Healthcare AI Tools to Support Profitable Shift to Value-Based Care

Adageis offers an AI-powered financial technology platform tailored to healthcare providers seeking a financially positive…

5 days ago

Scientists ID Bacteria That Could Be Behind Multiple Sclerosis Development

A new study focusing on twins has found that individuals with a larger presence of…

5 days ago